Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients

Figure 1 Continuously monitoring the development of signals in parallel standards and samples results in a series of amplification curves. The amplification of a 198 bp fragment of the generated hTERT cDNA was identified. (A: Signal from RMCCA1; B: Signal from HuCCA1; C, D: Signals from serum of cholangiocarcinoma patients; E, F: Signals from serum of benign biliary tract patients).